MAPT and Brain atrophy: In the hTau mouse model, characterized by human MAPT overexpression, TREM2 deficiency accelerates tau phosphorylation and aggregation during early disease progression, although its impact on neurodegeneration and brain atrophy has not been fully assessed [101].